Cellid applies for Phase 3 clinical trials in S.Korea for COVID-19 vaccine

Cellid applies for Phase 3 clinical trials in S.Korea for COVID-19 vaccine

South Korean bio-venture Cellid Co. announced on Tuesday that it has applied for the clinical Phase 3 trial of the COVID-19 Omicron variant-specific...

Vaxcell-Bio, Cellid sign MOU to build cancer immunotherapy platform

Vaxcell-Bio, Cellid sign MOU to build cancer immunotherapy platform

Vaxcell-Bio Therapeutics, a South Korean company specializing in anti-cancer immunotherapy, announced on Wednesday its partnership with Cellid Co. t...

Kakao Pay backs out of acquisition deal for SSG Pay, Smile Pay Hanwha in talks to buy five-star hotel Paraspara Seoul Kia's Lego-like PV5 with 16 variants to hit market in July Stray Kids make K-pop history with landmark stadium show in Germany S.Korea’s most prominent business leader returns with all charges cleared
banner